Metformin, Type 2 Diabetes, and dementiaš§
.
A new study shows that in older people with diabetes, metformin, a medication widely used to treat diabetes, delays cognitive deterioration, and decreases the risk of dementia.
.
Previous studies have suggested that metformin can penetrate the blood-brain barrier, protecting neurons via anti-inflammatory action and improvement of brain energy metabolism. This fact led the scientist to test the effect of metformin on cognitive function in patients with abnormal glucose metabolism.
.
š¬A six-year study of older Australians (aged 70 to 90 years old at baseline), has revealed a link between metformin use, slower cognitive decline, and lower dementia rates.
.
People living with type 2 diabetes have a staggering 60% risk of developing dementia. Individuals with type 2 diabetes taking metformin had a significantly slower cognitive decline and lower dementia risk compared to those not taking metformin.
.
This observational study does not provide conclusive āproofā that metformin is protective against dementia, but more research (randomized controlled trial) will help us to establish a definitive effect of metformin on dementia.
.
Research study:
.
šFollow us for more brain facts, news, and tips on how to preserve your brain health.
.
.
.
#braindisease #brainhealth #metformin #healthconsultation #healthybrain #healthcoaching #brainhealthcoach #neurocoach #neurocoaching #insulinresistance #functionalmedicine #alternativemedicine #healthassesment #healthiswealth #dementiaprevention #diabetic #brainpower #insulinresistant #alzheimersdisease #neurology #insulinresistancediet #neurodegenerativediseases #type2diabetic #chronicdisease #insulinsensitivity #neurodegenerativediseases #preventativemedicine
Comments